Ketamine vs. Antidepressants: Onset, Efficacy, Side Effects (2026)

Depression and anxiety are widespread mental health conditions, affecting millions globally. When it comes to treatment, various approaches are available, including traditional SSRIs (Selective Serotonin Reuptake Inhibitors) such as Zoloft and Prozac, SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) such as Cymbalta or Effexor, and ketamine. In this article, we compare these treatments, examining their mechanisms, efficacy, and considerations for patients.

Mechanisms of Action

Ketamine

Ketamine, initially used as an anesthetic, has emerged as a rapid-acting antidepressant. Its precise mechanisms are not fully understood, but it is thought to modulate glutamate receptors, facilitating synaptic plasticity. Ketamine offers quick relief, often within hours to days. For a deeper look at the science, see our post on how ketamine works.

SSRIs

SSRIs primarily function by increasing serotonin levels in the brain, which takes several weeks to produce the full therapeutic effects. They offer a well-established treatment option for depression and anxiety.

SNRIs

SNRIs work by increasing the availability of both serotonin and norepinephrine in the brain. They are effective in addressing both mood and anxiety disorders, targeting a broader range of symptoms.

Efficacy

Ketamine

Ketamine treatment has shown remarkable efficacy, especially for treatment-resistant depression, offering rapid relief. Clinical studies have reported significant improvements in mood, making it a promising option for those in acute distress. For background on the diagnosis itself, see our guide on understanding treatment-resistant depression, and on why ketamine works after 2+ antidepressants have failed.

SSRIs

SSRIs are widely regarded as effective for many individuals, with most experiencing reduced symptoms over time. Response rates may vary, and some patients may need to try different SSRIs to find the most suitable one.

SNRIs

SNRIs, similar to SSRIs, are effective for mood and anxiety disorders, providing relief for a broader range of symptoms. They are commonly prescribed when SSRIs alone are insufficient.

Administration and Treatment Considerations

Ketamine

Ketamine is typically administered through intravenous infusions, nasal sprays, or oral tablets and lozenges under professional supervision. Maintenance doses are often necessary for sustained relief. Its rapid action is valuable for those in immediate distress. Full remission is achievable for roughly 30 to 50 percent of treatment-resistant patients on a complete induction course.

SSRIs and SNRIs

SSRIs and SNRIs are available in oral forms, taken regularly over an extended period. The treatment with these drugs is generally long-term, often spanning several months or years. They are considered safe and are administered on an outpatient basis. Full remission on a single SSRI trial is less common (roughly 10 to 20 percent of patients with treatment-resistant depression), and many patients need to cycle through several agents before finding a match.

Side Effects and Safety

Ketamine

Ketamine may induce side effects such as dissociation, hallucinations, nausea, and increased blood pressure, but these are typically short-lived and manageable. Long-term safety data is still limited, and concerns exist regarding potential abuse or addiction, though unlikely with proper safety protocols.

Traditional SSRIs and SNRIs

SSRIs and SNRIs have a favorable safety profile for most patients, with side effects usually mild and transient. They can cause sexual dysfunction, weight gain, and withdrawal-like symptoms when the medication is discontinued.

Patient Considerations

The choice between ketamine, traditional SSRIs, and SNRIs should consider individual patient factors, such as:

• Severity of symptoms
• Treatment history
• Tolerance of side effects
• Desire for rapid relief
• Long-term treatment goals

Conclusion

Ketamine and traditional treatment with SSRIs and SNRIs represent distinct strategies for addressing depression and anxiety. Ketamine offers rapid relief, making it valuable for treatment-resistant cases. Traditional antidepressants, including SSRIs and SNRIs, are widely accepted and considered safe for most patients. The choice should be made in consultation with a healthcare provider, considering the unique needs and preferences of the individual. Ongoing research is crucial to expand our understanding of the long-term safety and efficacy of ketamine and to continue improving treatment options for mental health conditions.

Frequently Asked Questions

How fast does ketamine work compared to SSRIs?

Most patients notice a shift in mood, anxiety, or sleep within 24 to 72 hours of their first ketamine session. SSRIs typically take 4 to 6 weeks to reach full therapeutic effect. The mechanisms are different: ketamine drives a rapid burst of glutamate signaling, BDNF release, and synaptic regrowth, while SSRIs produce gradual brain adaptation to higher serotonin availability over weeks.

Can I take ketamine and an SSRI at the same time?

Yes, in most cases. SSRIs and SNRIs do not block ketamine's antidepressant effect, so patients are usually instructed to continue their current antidepressant during a ketamine course. The notable exceptions are benzodiazepines (Xanax, Klonopin, Ativan), which blunt ketamine's effect and should be held on session day, and lamotrigine (Lamictal), which can also reduce response. Discuss your full medication list with your prescribing physician before starting.

Will I have to stop my current antidepressant before starting ketamine?

Almost never. Most patients continue their SSRI or SNRI throughout ketamine treatment, since stopping abruptly can cause discontinuation symptoms and is rarely clinically necessary. If a future medication change makes sense, your physician will plan a gradual taper coordinated with your original prescriber, not a sudden swap.

Is ketamine a replacement for SSRIs or an addition to them?

It depends on your situation. For patients who have responded poorly to multiple SSRIs and SNRIs, ketamine often becomes the primary treatment with the antidepressant tapered off later. For patients who get partial relief from an SSRI but want more, ketamine is added on top to deepen response. For patients who have never tried an antidepressant, SSRIs are usually still the first-line treatment because of their longer track record and lower cost.

What response rate does ketamine have for treatment-resistant depression?

Meta-analyses of ketamine for treatment-resistant depression consistently report response rates (defined as a 50 percent or greater reduction in depression symptom scores) in the 60 to 75 percent range within 24 to 72 hours of a single dose. Full remission rates are lower, in the 30 to 50 percent range, and a complete induction course of 10 or more sessions tends to produce more durable benefit than a single session.

Are ketamine side effects worse than SSRI side effects?

They are different in profile. Ketamine produces short-term dissociation, mild blood pressure increase, and occasional nausea during sessions, with effects that fully resolve within hours. SSRIs produce sexual dysfunction, weight changes, sleep disruption, and emotional flattening that often persist as long as the medication is taken. Most patients tolerate both classes well; the trade-offs depend on which side-effect profile fits your life better.

When should someone switch from SSRIs to ketamine?

The most common moment is after two or more adequate antidepressant trials (each at therapeutic dose for 6 to 8 weeks) have failed to produce meaningful improvement. That clinical picture is treatment-resistant depression, and it is exactly the population for which ketamine has the strongest evidence. Other reasonable triggers: severe depression where waiting six weeks for an SSRI to maybe work is not safe, or patients whose SSRI side effects are intolerable.

Ready to Start?

If traditional antidepressants have not provided the relief you need, ketamine therapy may offer a different path forward. Find out if you are a candidate.

Check Your Eligibility →

Discreet Ketamine provides at-home ketamine therapy supervised by Dr. Ben Soffer, a board-certified physician, to residents of Florida and New Jersey.